AMR partnership, GARDP AMR partnership gathers speedGARDP:?Six European states, together with the British Wellcome Trust and South Africa, have pledged €56.5m to help develop new antibiotics that break resistance. The ambitious goal of the Global Antibiotic … more ➔
Preparing for the next generation of biolo...Biomanufacturing?While the FDA and EMA have for the first time okayed the switch from batch to continuous manufacture of a pill – Janssen Cilag’s HIV protease inhibitor darunavir (Prezista) – theindustry … more ➔
Expanding scale and reachFlexible and reliable contract manufacturing and development have become the key success factor in the development of biopharmaceuticals. Due to the long process time and high investment needed to build … more ➔
insect economy, insect protein World Nutrition: Insects will be on every...Bioeconomy:?It could be a turning point for the fish meal and fish oil dependent animal feed industry in Europe. Since July, the European Commission has allowed the use of insect-processed animal proteins … more ➔
drug serialisation Rapid implemenation of off-line serialisat...Serialisation of drugs is confronting pharmaceutical companies all over the world with challenges, especially in relation to data handling and the integration of additional equipment and functions into … more ➔
Chromosome IV, Huntingtons disease The hunt for a cure for Huntington’sGenetic Diseases:?Its a disease that often strikes people in the prime of life, slowly destroying control over body, mind and personality. It inevitably kills the patient, but usually only after at … more ➔
Ayoxxa, diabetic retinopathy, Lunaris Insight into biomarkersAYOXXAs LUNARIS platform:?In a case study "Translational proteomics: a new perspective for ophthalmology research, Ayoxxa gives insights into the capabilities of its Lunaris multiplex protein … more ➔
Bright future for biomanufacturersProgress in process engineering and media optimisation has resulted in significant productivity increases in upstream processing driving transformations at drug developers and CDMOs. At BPI Europe in … more ➔
CRISPR & Co.: Brave new foodThe possibilities offered by CRISPR/Cas9, TALENs and other new genome editing technologies are making the mouths of plant breeders water – and not just because the methods give seed developers new options … more ➔
Checkpoint modulation: Blocking the tumour...Belgian, Swiss, and US researchers have found a new way to boost efficacy in cancer immunotherapy. In mid-April, they reported that cancer cells actively block tumour infiltration of cytotoxic T cells, … more ➔
